Statements (51)
Predicate | Object |
---|---|
gptkbp:instanceOf |
gptkb:healthcare_organization
|
gptkbp:affiliatedWith |
gptkb:Duke_University
|
gptkbp:collaboratesWith |
gptkb:National_Cancer_Institute
other research institutions |
gptkbp:conducts |
research
|
gptkbp:focusesOn |
cancer treatment
|
gptkbp:hasAwards |
accreditations
Best_Hospitals_rankings NCI_Designation |
gptkbp:hasDepartment |
hematology
surgical oncology medical oncology radiation oncology |
gptkbp:hasLocalCuisine |
Phase III trials
Phase I trials Phase II trials Phase IV trials |
gptkbp:hasPrograms |
lung cancer
breast cancer prostate cancer pediatric oncology leukemia lymphoma gastrointestinal cancer neuro-oncology |
gptkbp:hasPublications |
clinical guidelines
research reports peer-reviewed articles |
gptkbp:hasTechnology |
genomic sequencing
advanced imaging technology clinical trial management systems robotic surgery systems radiation therapy equipment |
gptkbp:hostsEvents |
fundraising events
educational seminars cancer awareness campaigns |
https://www.w3.org/2000/01/rdf-schema#label |
Duke Cancer Institute
|
gptkbp:isPartOf |
gptkb:Duke_Health
|
gptkbp:isRecognizedFor |
patient-centered care
innovative cancer therapies multidisciplinary approach to cancer care |
gptkbp:locatedIn |
gptkb:Durham,_North_Carolina
|
gptkbp:offers |
clinical trials
|
gptkbp:offersServices |
rehabilitation services
nutritional counseling psychosocial support pain management |
gptkbp:provides |
patient care
|
gptkbp:receivesFundingFrom |
government grants
pharmaceutical companies private donations |